United Action for Better Health in Europe
On 12-14 September 2022, representatives from civil society, partnering organizations, and the 53 Member States of the WHO European Region met in Tel Aviv, Israel for the 72nd governance session. The session…
Living donor transplantation offers a safe alternative for liver transplant patients
Amsterdam, September 26, 2022 – Demand for donor livers for transplant patients outstrips supply with over 15% of waitlist patients dying after a year. A new international study offers support for increasing…
Introducing the new EASL Membership structure
From the very beginning, EASL’s mission has been to be the “Home of Hepatology”. Providing education to everyone interested in hepatology and engaging with all stakeholders in the liver field wherever they…
Treatment in Pregnancy for Hepatitis C (TiP-HepC) Clinical Case Registry
Although DAA medications have demonstrated excellent safety and efficacy in non-pregnant individuals, they are not currently approved for HCV treatment in pregnant women due to a lack of safety data. Clinical trials…
NAFLD Nomenclature Consensus Meeting High-Level Output
The 2-day meeting in Chicago on 8-9 July 2022 convened 129 consensus survey participants in person or online. The participants originated from 32 countries, representing multiple societies including AASLD, EASL, APASL, ALEH,…
Liver disease UK deaths soar by 400% since 1970
28 July 2022
